Inhaled voriconazole for prevention of invasive pulmonary aspergillosis

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 6, 2009, Pages 2613-2615

  Tolman, Justin A ^a   Wiederhold, Nathan P ^a,b   McConville, Jason T ^a   Najvar, Laura K ^b,c   Bocanegra, Rosie ^b,c   Peters, Jay I ^b,c   Coalson, Jacqueline J ^d   Graybill, John R ^b   Patterson, Thomas F ^b,c   Williams III, Robert O ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^d University of Texas Health Science Center at San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; BETA CYCLODEXTRIN SULFOBUTYL ETHER; VORICONAZOLE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; INFECTION PREVENTION; LUNG ASPERGILLOSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; INVASIVE PULMONARY ASPERGILLOSIS; MICE; MICE, INBRED ICR; PYRIMIDINES; TRIAZOLES;

EID: 67049107823     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01657-08     Document Type: Article

References (12)

1. Alexander, B. D., E. S. Dodds Ashley, R. M. Addison, J. A. Alspaugh, N. J. Chao, and J. R. Perfect. 2006. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation. Transpl. Infect. Dis. 8:13-20.
2. Bowman, J. C., G. K. Abruzzo, J. W. Anderson, A. M. Flattery, C. J. Gill, V. B. Pikounis, D. M. Schmatz, P. A. Liberator, and C. M. Douglas. 2001. Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate. Antimicrob. Agents Chemother. 45:3474-3481.
3. Denning, D. W. 1998. Invasive aspergillosis. Clin. Infect. Dis. 26:781-805.
4. Dummer, J. S., N. Lazariashvilli, J. Barnes, M. Ninan, and A. P. Milstone. 2004. A survey of anti-fungal management in lung transplantation. J. Heart Lung Transplant. 23:1376-1381. (Pubitemid 40018160)
5. Lin, S. J., J. Schranz, and S. M. Teutsch. 2001. Aspergillosis case-fatality rate: systematic review of the literature. Clin. Infect. Dis. 32:358-366.
6. Rijnders, B. J., J. J. Cornelissen, L. Slobbe, M. J. Becker, J. K. Doorduijn, W. C. Hop, E. J. Ruijgrok, B. Lowenberg, A. Vulto, P. J. Lugtenburg, and S. de Marie. 2008. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial. Clin. Infect. Dis. 46:1401-1408.
7. Sheppard, D. C., J. R. Graybill, L. K. Najvar, L. Y. Chiang, T. Doedt, W. R. Kirkpatrick, R. Bocanegra, A. C. Vallor, T. F. Patterson, and S. G. Filler. 2006. Standardization of an experimental murine model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 50:3501-3503.
8. Sheppard, D. C., G. Rieg, L. Y. Chiang, S. G. Filler, J. E. Edwards, Jr., and A. S. Ibrahim. 2004. Novel inhalational murine model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 48:1908-1911.
9. Slobbe, L., S. Polinder, J. K. Doorduijn, P. J. Lugtenburg, A. el Barzouhi, E. W. Steyerberg, and B. J. Rijnders. 2008. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study. Clin. Infect. Dis. 47:1507-1512.
10. Tolman, J. A., N. A. Nelson, Y. J. Son, S. Bosselmann, N. P. Wiederhold, J. T. McConville, and R. O. Williams III. 2009. Characterization and pharmacokinetic analysis of aerosolized aqueous voriconazole solution. Eur. J. Pharm. Biopharm. 72:199-205.
11. Wiederhold, N. P., L. K. Najvar, A. C. Vallor, W. R. Kirkpatrick, R. Bocanegra, D. Molina, M. Olivo, J. R. Graybill, and T. F. Patterson. 2008. Assessment of serum (1→3)-β-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 52:1176-1178.
12. Wiederhold, N. P., V. H. Tam, J. Chi, R. A. Prince, D. P. Kontoyiannis, and R. E. Lewis. 2006. Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 50:469-473.